Abstract
Sleep disturbances, as well as other CNS side effects, can be caused by a large variety of therapeutic drugs used for the treatment of a wide range of neurological, psychiatric and medical conditions. Disordered sleep can present itself as the only or main side effect or it can be one of several side effects caused by a particular drug.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abramowicz M (1989) Drugs for epilepsy. The Med Let 31:1–4
Abramowicz M (1991) Drugs for psychiatric disorders. Med Let 33:43–50
Adam K, Oswald I (1989) Can a rapidly-eliminated hypnotic cause daytime anxiety? Pharmacopsychiatr 22:115–119
Ahmann PA, Waltonen SJ, Olson KA, Theye FW, VanErem AJ, LaPlant RJ (1993) Placebo-controlled evaluation of ritalin side effects. Pediatrics 91:1101–1106
Akindele MO, Evans JI, Oswald I (1970) Mono-amine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol 29:47–56
Albala AA, Weinberg N, Allen SM (1983) Maprotiline-induced hypnopompic hallucinations. J Clin Psychiatry 44:149–150
Aldrich MS, Rogers AE (1989) Exacerbation of human cataplexy by prazosin. Sleep 12(3):254–256
Alexander CM, Gross JB (1988) Sedative doses of midazolam depress hypoxic ventilatory responses in humans. Anesth Analg 67:377–382
Alvi MY (1969) Unusual effects of fenfluramine. Br Med J 4:237
Ancoli-Israel S, Kripke DF, Mason W (1987) Characteristics of obstructive and central apnea in the elderly: an interim report. Biol Psychiatry 22:741–750
Andersson KE, Persson CGA (1980) Extrapulmonary effects of theophylline. Eur J Resp Dis Sup 61:17–28
Avital A, Steljes DG, Pasterkamp H, Kryger M, Sanchez I, Chernick V (1991) Sleep quality in children with asthma treated with theophylline or cromolyn sodium. J Pediatr 119:979–984
Bakht FR, Miller LG (1991) Naproxen-associated nightmares. Southern Med J 84:1271–1273
Barkley RA, McMurray MB, Edelbrock CS, Robbins K (1990) Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation. Pediatrics 86:184–192
Bassuk EL, Schoonover SC, Gelenberg AJ (eds) (1983) The practitioner’s guide to psychoactive drugs, 2nd edn. Plenum, New York
Beasley CM, Dornseif BE, Pultz JA, Bosomworth JC, Sayler ME (1991) Fluoxetine versus trazodone: efficacy and activating-sedating effects. J Clin Psychiatry 52:294–299
Becker PM, Jamieson AO, Brown WD (1993) Dopaminergic agents in restless legs syndrome and periodic limb movements of sleep: response and complications of extended treatment in 49 cases. Sleep 16:713–716
Bender W, Greil W, Ruther E, Schnelle K (1979) Effects of the β-adrenoceptor blocking agent sotalol in CNS: sleep, EEG, and psychophysiological parameters. J Clin Pharmacol 19:505–512
Bental E, Lavie P, Sharf B (1979) Severe hypermotility during sleep in treatment of cataplexy with clomipramine. Isr J Med Sci 15:607–609
Besset A (1978) Effect of antidepressants and sleep. Adv Biosci 21:141–148
Betts TA (1981) Adrenoceptor drugs and sleep. In: Wheatley D (ed) Psychopharmacology of sleep. Raven, New York, pp 199–212
Betts TA, Alford C (1985) Beta-blockers and sleep: a controlled trial. Eur J Clin Pharmacol 28:65–68
Bixler EO, Kales A, Brubaker BH, Kales JD (1987) Adverse reactions to benzodiazepine hypnotics: spontaneous reporting system. Pharmacology 35:286–300
Block AJ, Boysen PG, Wynne JW, Hunt LA (1979) Sleep apnea, hypopnea, and oxygen desaturation in normal subjects: a strong male predominance. N Engl J Med 300:513–517
Block AJ, Wynne JW, Boysen PG (1980) Sleep-disordered breathing and nocturnal oxygen desaturation in postmenopausal women. Am J Med 69:75–79
Block AJ, Dolly FR, Slayton PC (1984) Does flurazepam ingestion affect breathing and oxygenation during sleep in patients with chronic obstructive lung disease? Am Rev Respir Dis 129:230–233
Bonnet MH, Dexter JR, Arand DL (1990) The effect of triazolam on arousal and respiration in central sleep apnea patients. Sleep 13:31–41
Bonora M, Shields G, Knuth S, Bartlett D, St. John WM (1984) Selective depression by ethanol of upper airway respiratory motor activity in cats. Am Rev Respir Dis 130:156–161
Boudoulas H, Schmidt H, Geleris P, Clarke RW, Lewis RP (1983) Case reports on deterioration of sleep apnea during therapy with propranolol — preliminary studies. Res Commum Chem Pathol Pharmacol 39:3–10
Boyson SJ (1991) Psychiatric effects of selegiline. Arch Neurol 48:902
Brent DA, Grumbine PK, Yarma RR, Allan M, Allman C (1987) Phenobarbitol treatment and major depressive disorder in children with epilepsy. Pediatrics 80:909–917
Broughton RJ (1968) Sleep disorders: disorders of arousal? Science 159:1070–1078
Broughton RJ, Gastaut H (1975) Recent sleep research on enuresis nocturna, sleepwalking, sleep terrors and confusional arousals. In: Levin P, Koella WP (eds) Sleep 1974. Second European Congress of Sleep Research, Rome 1975, pp 82–91
Burke BM (1993) Mefloquine. Lancet 341:1605–1606
Caillon E, Schmitt L, Moron P (1992) Acute depressive symptoms after mefloquine treatment. Am J Psychiatry 149:712
Carruthers SG, Shoeman DW, Hignite CE, Azarnoff DL (1978) Correlation between plasma diphenhydramine level and sedative and antihistamine effects. Clin Pharmacol Ther 23:375–382
Carskadon MA, Seidel WF, Greenblatt DJ, Dement WC (1982) Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 5:361–371
Catchlove RFH, Kafer ER (1971a) The effects of diazepam on the ventilatory response to carbon dioxide and on steady-state gas exchange. Anesthesiology 34:9–13
Catchlove RFH, Kafer ER (1971b) The effects of diazepam on respiration in patients with obstructive pulmonary disease. Anesthesiology 34:14–18
Catley DM, Thornton C, Jordan C, Lehane JR, Royston D, Jones JG (1985) Pronounced, episodic oxygen desaturation in the postoperative period. Its association with ventilatory pattern and analgesic regimen. Anesthesiology 63:20–28
Chan CS, Grunstein RR, Bye PTP, Woolcock AJ, Sullivan CE (1989) Obstructive sleep apnea with severe chronic airflow limitation. Am Rev Respir Dis 140: 1274–1278
Charney DS, Kales A, Soldatos CR, Nelson JC (1979) Somnambulistic-like episodes secondary to combined lithium-neuroleptic treatment. Br J Psychiatry 135: 418–424
Chernik DA, Mendels J (1974) Longitudinal study of the effects of lithium carbonate on the sleep of hospitalized depressed patients. Biol Psychiatry 9:117–23
Christianson HB, Perry HO (1956) Reactions to chloral hydrate. Arch Dermatol 74:232–240
Chrousos GA, Kattah JC, Beck RW, Cleary PA, and the Optic Neuritis Study Group (1993) Side effects of glucocorticoid treatment. JAMA 269:2110–2112
Church MW, Johnson LC (1979) Mood and performance of poor sleepers during repeated use with flurazepam. Psychopharmacology 61:309–316
Clark TJH, Collins JV, Tong D (1971) Respiratory depression caused by nitrazepam in patients with respiratory failure. Lancet II:737–738
Clarke CH, Nicholson AN (1978) Performance studies with antihistamines. Br J Clin Pharmacol 6:31–36
Clyburn PA, Rosen M, Vickers MD (1990) Comparison of the respiratory effects of IV infusions of morphine and regional analgesia by extradural block. Br J Anaesth 64:446–449
Cove-Smith JR, Kirk CA (1985) CNS-related side effects with metoprolol and atenolol. Eur J Clin Pharmacol 28:69–72
Craddock M, Lees DE (1987) Anesthesia for obstructive sleep apnea patients: risks, precautions, and management. In: Fairbanks DNF (ed) Snoring and obstructive sleep apnea. Raven, New York, pp 235–243
Cruickshank JM, Neil-Dwyer GN (1985) β-Blocker brain concentrations in man. Eur J Clin Pharmacol 28:21–23
Cummiskey J, Guilleminault C, Del Rio G, Silverstri R (1983) The effects of flurazepam on sleep studies in patients with chronic obstructive pulmonary disease. Chest 84:143–147
Davies DM (ed) (1985) Textbook of adverse drug reactions, 3rd edn. Oxford University Press, New York
Davis JM, Glassman AH (1989) Antidepressant drugs. In: Kaplan HI, Sadock BJ (eds) Comprehensive textbook of psychiatry, 5th edn: vol 2. Williams and Wilkins, Maryland, pp 1627–1655
Demet E, Chicz-Demet A (1987) Effects of psychoactive drugs on circadian rhythms. Psychiatric Ann 17:682–688
Dietrich B, Herrmann WM (1989) Influence of cilazapril on memory functions and sleep behaviour in comparison with metoprolol and placebo in healthy subjects. Br J Clin Pharmacol 27:249S-261S
Dobson ME, Yousseff Y, Maddison S, Pleuvry B (1976) Respiratory effects of lorazepam. Br J Anaesth 48:611–612
Dolly FR, Block AJ (1982) Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73:239–243
Drake ME (1988) Restless legs with antiepileptic drug therapy. Clin Neurol Neurosurg 90:151–154
Dunleavy DLF, MacLean AW, Oswald I (1971) Debrisoquine, guanethidine, propranolol and human sleep. Psychopharmacology (Berl) 21:101–110
Edling C, Lindberg A, Ulfberg J (1993) Occupational exposure to organic solvents as a cause of sleep apnoea. Br J Ind Med 50:276–279
Etches RC (1994) Respiratory depression associated with patient-controlled analgesia: a review of eight cases. Can J Anaesth 41:125–132
Feinberg I, Wender PH, Koresko RL, Gottlieb F, Piehuta JA (1969) Differential effects of chlorpromazine and phenobarbital on EEG sleep patterns. J Psychiatr Res 7:101–109
Fitzpatrick MF, Engleman HM, Boellert F, McHardy R, Shapiro CM, Deary IJ, Douglas NJ (1992) Effect of therapeutic theophylline levels on the sleep quality and daytime cognitive performance of normal subjects. Am Rev Respir Dis 145:1355–1358
Flaherty JA, Bellur SN (1981) Mental side effects of amantadine therapy: its spectrum and characteristics in a normal population. J Clin Psychiatry 42:344–345
Flemenbaum A (1976) Pavor nocturnus: a complication of single daily tricyclic or neuroleptic dosage. Am J Psychiatry 133:570–572
Fletcher EC, DeBehnke RD, Lovoi MS, Gorin MB (1985a) Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 103:190–195
Fletcher EC, Lovoi M, Miller J, Schaaf J, Flournoy DJ (1985b) Propranolol and sleep apnea (abstract). Am Rev Respir Dis 131:A103
Foerster E-Ch, Greminger P, Siegenthaler W, Vetter H, Vetter W (1985) Atenolol versus pindolol: side-effects in hypertension. Eur J Clin Pharmacol 28:89–91
Forrest WH, Bellville JW (1964) The effect of sleep plus morphine on respiratory response to carbon dioxide. Anesthesiology 25:137–141
Freeman CPL, Trimble MR, Deakin JFW, Stokes TM, Ashford JJ (1994) Fluvoxamine versus clomipramine in the treatment of obsessive compulsive disorder: a multicenter, randomized, double-blind, parallel group comparison. J Clin Psychiat 55:301–305
Gastaut H, Broughton R (1965) A clinical and polygraphic study of episodic phenomena during sleep. In: Wortis J (ed) Recent advances in biological psychiatry. Plenum, New York, pp 197–221
Goodwin FK (ed) (1979) The lithium ion: impact on treatment and research. Arch Gen Psychiatry 36:833–916
Goodwin FK, Bunney WE (1971) Depressions following reserpine: a reevaluation. Semin Psychiatry 3:435–448
Graham JR (1964) Methysergide for prevention of headache. N Engl J Med 270: 67–72
Greenblatt DJ, Shader RI, Abernethy DR, Ochs HR, Divoll M, Sellers EM (1982) Benzodiazepines and the challenge of pharmacokinetic taxonomy. In: Usdin E, Skolnick P, Tallman JF Jr, Greenblatt D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan, London, pp 257–270
Gross JB, Zebrowske ME, Carel WD, Gardner S, Smith TC (1983) Time course of ventilatory depression with thiopental and midazolam in normal subjects and in patients with chronic obstructive pulmonary disease. Anesthesiology 58:540–544
Guilleminault C, Cummiskey J, Silvestri R (1982) Benzodiazepines and respiration during sleep. In: Udsin E, Clarke P, Tellman D, Paul SM (eds) Pharmacology of benzodiazepines. London, Macmillan, pp 229–236
Guilleminault C, Raynal D, Takahaski S, Carskadon M, Dement W (1976a) Evaluation of short-term and long-term treatment of the narcolepsy syndrome with clomipramine hydrochloride. Acta Neurol Scand 54:71–87
Guilleminault C, Tilkian A, Dement WC (1976b) The sleep apnea syndromes. Annu Rev Med 27:465–484
Guilleminault C, Cummiskey J, Silverstri R (1978) Benzodiazepines and respiration during sleep. In: Usdin E, Skolnick P, Tallman JF Jr, Greenblatt D, Paul SM (eds) Pharmacology of benzodiazepines. MacMillan, London, pp 229–236
Guillemnault C, Silvestre R, Mondini S, Coburn S (1984) Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol and sleep deprivation in a healthy elderly group. J Gerontol 39:655–661
Guillemnault C, Crowe C, Quera-Salva MA, Miles L, Partinen M (1988) Periodic leg movement, sleep fragmentation and central sleep apnea in two cases: reduction with clonazepam. Eur Respir J 1:762–765
Haffner CA, Smith BS, Pepper C (1993) Hallucinations as an adverse effect of angiotensin converting enzyme inhibition. Postgrad Med J 69:240
Haponik EF, Smith PL, Bohlman ME, Allen RP, Goldman SM, Blecker ER (1983) Computerized tomography in obstructive sleep apnea. Am Rev Respir Dis 127:221–226
Heiman EM, Christie M (1986) Lithium-aggravated nocturnal myoclonus and restless legs syndrome (letter). Am J Psychiatry 143:1191–1192
Hindmarch I (1979) Effects of hypnotic and sleep-inducing drugs on objective assessment of human psychomotor performance and subjective appraisals of sleep and early morning behaviour. Br J Pharmacol 8:435–465
Hindmarch I, Parrott AC (1978) A repeated dose comparison of the side effects of five antihistamines on objective assessments of psychomotor performance, central nervous system arousal and subjective appraisals of sleep and early morning behaviour. Arzneimittelforschung 28:483–486
Hoch CC, Reynolds CF, Monk TH, Buysse DJ, Yeager AL, Houck PR, Kupfer DJ (1990) Comparison of sleep-disordered breathing among healthy elderly in the seventh, eighth, and ninth decades of life. Sleep 13:502–511
Hollister LE, Csernansky JG (1990) Clinical pharmacology of psychotherapeutic drugs. Churchill Livingston, New York, p 194
Holm AC, Edsman I, Lundberg T, Odlind B (1993) Tolerability of remoxipride in the long term treatment of schizophrenia. Drug Safety 8:445–456
Hooper AC (1971) Fenfluramine and dreaming. BMJ 3:305
Huapaya LVM (1979) Seven cases of somnambulism induced by drugs. Am J Psychiatry 136:985–986
Jacobson A, Kales A, Lehmann D, Wenner WH (1965) Somnambulism: all-night electroencephalographic studies. Science 148:975–977
Jaffe JH (1990) Drug addiction and drug abuse. In: Goodman LS, Gilman A (eds) Pharmacological basis of therapeutics, 8th edn. Pergamon, New York, pp 522–573
Jaffe JH, Martin WR (1990) Opioid analygesics and antagonists. In: Goodman, Gilman’s (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 485–521
Johnson LC, Chernick DA (1982) Sedative-hypnotics and human performance. Psychopharmacology 76:101–113
Johnson MW, Anch AM, Remmers JE (1984) Induction of the obstructive sleep apnea syndrome in a woman by exogenous androgen administration. Am Rev Respir Dis 129:1023–1025
Jus K, Beland C, Jus A, Fontaine P, Brunelle R, Bouchard M (1975) Polygraphic night sleep pattern during chronic single and multiple dose administration. Int Pharmacopsychiatry 10:58–63
Kales A, Jacobson A (1967) Studies of mental activity: Recall somnambulism and effects of REM deprivation and drugs. Exp Neurol 19:81
Kales A, Scharf MB (1973) Sleep laboratory and clinical studies of the effects of benzodiazepines on sleep: flurazepam, diazepam, chlordiazepoxide, and RO 5–4200. In: Garatini S, Mussini E, Randall LO (eds) The benzodiazepines. Raven, New York, pp 577–598
Kales A, Kales JD (1984) Evaluation and treatment of insomnia. Oxford University Press, New York
Kales A, Vgontzas A (1990) Not all benzodiazepines are alike. In: Stefanis CN, Rabavilas AD, Soldatos CR (eds) Psychiatry: a world perspective, vol 3. Elsevier, Amsterdam, pp 379–384
Kales A, Jacobson A, Paulson MJ, Kales JD, Walter RD (1966) Somnambulsim: psychophysiological correlates. I. All-night EEG studies. Arch Gen Psychiatry 14:586–594
Kales A, Bixler EO, Tan TL, Scharf MB, Kales JD (1974) Chronic hypnotic-drug use: ineffectiveness, drug-withdrawal insomnia, and dependence. JAMA 227:513–517
Kales A, Bixler EO, Scharf MB, Kales JD (1976a) Sleep laboratory studies of flurazepam: a model for evaluating hypnotic drugs. Clin Pharmacol Ther 19:576–583
Kales A, Kales JD, Bixler EO, Scharf MB, Russek E (1976b) Hypnotic efficacy of triazolam: sleep laboratory evaluation of intermediate-term effectiveness. J Clin Pharmacol 16:399–406
Kales A, Kales JD, Jacobson A, Humphrey JF II, Soldatos CR (1977) Effects of imipramine on enure tic frequency and sleep stages. Pediatrics 60:431–436
Kales A, Scharf MB, Kales JD (1978) Rebound insomnia: a new clinical sydrome. Science 201:1039–1041
Kales A, Scharf MB, Kales JD, Soldatos CR (1979) Rebound insomnia: a potential hazard following withdrawal of certain benzodiazepines. JAMA 241:1692–1695
Kales A, Soldatos CR, Kales JD (1981) Sleep disorders: evaluation and management in the office setting. In: Arieti S, Brodie HKH (eds) American handbook of psychiatry, 2nd edn: vol 7. Basic Books, New York, pp 423–454
Kales A, Bixler EO, Soldatos CR, Vela-Bueno A, Jacoby J, Kales JD (1982) Quazepam and flurazepam: long-term use and extended withdrawal. Clin Pharmacol Ther 32:781–788
Kales A, Soldatos CR, Bixler EO, Goff PJ, Vela-Bueno A (1983a) Midazolam: dose-response studies of effectiveness and rebound insomnia. Pharmacology 26:138–149
Kales A, Soldatos CR, Bixler EO, Kales JD (1983b) Early morning insomnia with short-acting benzodiazepines. Science 220:95–97
Kales A, Soldatos CR, Bixler EO, Kales JD (1983c) Rebound insomnia and rebound anxiety: a review. Pharmacology 26:121–137
Kales A, Cadieux RJ, Shaw LC, Vela-Bueno A, Bixler EO, Schneck DW, Locke TW, Soldatos CR (1984) Sleep apnea in a hypertensive population. Lancet II:1005–1008
Kales A, Cadieux RJ, Bixler EO, Soldatos CR, Vela-Bueno A, Misoul CA, Locke TW (1985) Severe obstructive sleep apnea-I: onset, clinical course and characteristics. J Chron Dis 38:419–425
Kales A, Soldatos CR, Vela-Bueno A (1985) Clinical comparison of benzodiazepine hypnotics with short and long elimination half-lives. In: Smith DE, Wesson DR (eds) The benzodiazepines: current standards for medical practice. MTP Press, Maine, pp 121–147
Kales A, Bixler EO, Vela-Bueno A, Cadieux RJ, Manfredi RL, Bitzer S, Kanter T (1988) Effects on nadolol on blood pressure, sleep efficiency, and sleep stages. Clin Pharmacol Ther 43:655–662
Kales A, Bixler EO, Vela-Bueno A, Manfredi RL, Soldatos CR (1989) Effects on dreaming of two beta blockers (nadolol and propranolol). Excerpta Medica 899:689
Kales A, Manfredi RL, Vgontzas AN, Baldassano CF, Kostakos K, Kales JD (1991) Clonazepam: sleep laboratory study of efficacy and withdrawal. J Clin Psychopharmacol 11:189–193
Kales A, Vgontzas AN, Bixler EO (1994) Not all benzodiazepines are alike: update 1993. In: Biegel A, Lopez Ibor IJ, Costa e Silva JA (eds) Psychiatry: a world perspective, vol II. World Scientific, Singapore, pp 942–946
Kane FJ, Pokorny A (1975) Mental and emotional disturbance with pentazocine (talwin) use. South Med J 68:808–811
Kaplan J, Dawson S, Vaughan T, Green R, Wyatt RJ (1974) Effect of prolonged chlorpromazine administration on the sleep of chronic schizophrenics. Arch Gen Psychiatry 31:62–66
Kaplan J, Fredrickson PA, Renaux SA, O’Brien PC (1993) Theophylline effect on sleep in normal subjects. Chest 103:193–195
Kayed K, Godtlibsen OB (1977) Effects of the β-adrenoceptor antagonists acebutolol and metoprolol on sleep pattern in normal subjects. Eur J Clin Pharmacol 12:323–326
Keamy MF, Cadieux RJ, Kofke WA, Kales A (1987) The occurrence of obstructive sleep apnea in a recovery room patient. Anesthesiology 66:232–234
Keck PE Jr, Hudson JI, Dorsey CM, Campbell PI (1991) Effect of fluoxetine on sleep. Biol Psychiatry 29:618–625
Koella WP (1985) CNS-related (side-) effects of β-blockers with special reference to mechanisms of action. Eur J Clin Pharmacol 28:55–63
Kukopulos A, Reginaldi D, Laddomada P, Floris G, Serra G, Tondo L (1980) Course of the manic-depressive cycle and change caused by treatments. Pharmako-Psychiatrie Neuropsychopharmakologie 13:156–167
Kupfer D, Reynolds CF, Weiss BL, Foster FG (1974) Lithium carbonate and sleep in affective disorders. Arch Gen Psychiatry 30:79–84
Lakshminarayan S, Sahn SA, Hudson L, Weil JV (1976) Effects of diazepam on ventilatory responses. Clin Pharmacol Ther 20:178–183
Lamarche Y, Martin R, Reiher J, Blaise G (1986) The sleep apnoea syndrome and epidural morphine. Can Anaesth Soc J 33:231–233
Lauerma H (1991) Nocturnal wandering caused by restless legs and short-acting benzodiazepines. Acta Psychiatry Scand 83:492–493
Lavie Ben-Yosef R, Ami-Hai ER (1984) Prevalence of sleep apnea syndrome among patients with essential hypertension. Am Heart J 108:373–376
Leech JA, Onal E, Dulberg C, Lopata MA (1988) A comparison of men and women with occlusive sleep apnea syndrome. Chest 94:983–988
Lester BK, Coulter JD, Cowden LC, Williams HL (1971) Chlorpromazine and human sleep. Psychopharmacologia 20:280–287
Lewis SA, Oswald I, Dunleavy DLF (1971) Chronic fenfluramine administration: some cerebral effects. Br Med J 3:67–70
Longbottom RT, Pleuvry BJ (1984) Respiratory and sedative effects of triazolam in volunteers. Br J Anaesth 56:179–185
Luchins DJ, Sherwood PM, Gillin JC, Mendelson WB, Wyatt RJ (1978) Filicide during psychotropic-induced somnambulism: a case report. Am J Psychiatry 135:1404–1405
MacEvilly M, O’Carroll C (1989) Hallucinations after epidural buprenorphine. Br Med J 298:928–929
Mamelak M, Csima A, Price V (1984) A comparative 25 night sleep laboratory study on the effects of quazepam and triazolam on the sleep of chronic insomniacs. J Clin Pharmacol 24:65–75
Manfredi RL, Kales A, Vgontzas AN, Bixler EO, Isaac MA, Falcone CM (1991) Buspirone: sedative or stimulant effect? Am J Psychiatry 148:1213–1217
Marshall BE, Longnecker DE (1990) General anesthetics. In: Goodman, Gilman’s (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 285–310
Matsumoto AM, Sandbloom RE, Schoene RB, Leek A, Giblin EC, Pierson DJ (1985) Testosterone replacements in hypogonadal men: effects on sleep apnea, respiratory drives, and sleep. Clin Endocrinol 22:713–721
Mattila MJ, Mattila M, Konno K (1986) Acute and subacute actions on human performance and interactions with diazepam of temelastine (SK & F93944) and diphenhydramine. Eur J Pharmacol 31:291–298
Mayer J, Peter JH (1991) First experience with Cilazapril in the treatment of sleep apnoea related hypertension. Drugs 41:37–37
Mayer J, Weichler U, Herres-Mayer B, Schneider, Marx U, Peter JH (1990) Influence of metoprolol and Cilazapril on blood pressure and sleep apnea activity. J Cardiovasc Pharmacol 16:952–961
Meier-Ewert K, Matsubayashi K, Benter L (1985) Propranolol: long-term treatment in narcolepsy-cataplexy. Sleep 8:95–104
Mendelson WB, Garnett D, Gillin JC (1981) Flurazepam induced sleep apnea syndrome in a patient with insomnia and mild sleep-related respiratory changes. J Nerv Ment Dis 169:261–264
Mendelson WB (1991) Safety of short-acting benzodiazepine hypnotics in patients with impaired respiration. Am J Psychiatry 148:1401
Metes A, Ohki M, Cole P, Haight BM, Hoffstein V (1991) Snoring, apnea and nasal resistance in men and women. J Otolaryngol 20:57–61
Midgren B, Hansson L, Skeidsvoll H, Elmqvist D (1989) The effects of nitrazepam and flunitrazepam on oxygen desaturation during sleep in patients with stable hypoxemic nonhypercapnic COPD. Chest 95:765–768
Mignot E, Guilleminault C, Bowersox S, Kilduff T, Dement WC (1987) The effects of alpha-1 adrenoceptor agonist and antagonist in canine narcolepsy. Sleep Res 16:393
Mignot E, Guilleminault C, Bowersox S, Rappaport A, Dement WC (1988) A role of central alpha-1 adrenoceptors in canine narcolepsy. J Clin Invest 82:885–894
Miller RR (1975) Clinical effects of pentazocine in hospitalized medical patients. J Clin Pharmacol 15:198–205
Mitler MM, Carshadon MA, Phillips RL, Sterling WR, Zavcone VP, Spiegel R, Guilleminault C, Dement WC (1979) Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation. Br J Clin Pharmacol 8:635–685
Morgan K, Oswald I (1982) Anxiety caused by a short-life hypnotic. Br Med J 284:942
Mort JR (1992) Nightmare cessation following alteration of ophthalmic administration of a cholinergic and a beta-blocking agent. Ann Pharmacother 26:914–916
Moskowitz H, Burns M (1988) Effects of terfenadine, diphenhydramine, and placebo on skills performance. Cutis 42:14–18
Moskowitz C, Moses H, Klawans HL (1978) Levodopa-induced psychosis: a kindling phenomenon. Am J Psychiatry 6:669–675
Murciano D, Armengaud MH, Cramer PH, Neveux E, L’Heritier C, Pariente R, Aubier M (1993) Acute effects of zolpidem, triazolam and flunitrazepam on arterial blood gases and control of breathing in severe COPD. Eur Respir J 6:625–629
Nadel C (1981) Somnambulism, bed-time medication and over-eating. Br J Psychiatry 139:79
Neil-Dwyer G, Bartlett J, McAinsh J, Cruickshank JM (1981) β-Adrenoceptor blockers and the blood-brain barrier. Br J Clin Pharmacol 11:549–553
Newton RE, Casten GP, Alms DR, Benes CO, Marunycz JD (1982) The side effect profile of buspirone in comparison to active controls and placebo. J Clin Psychiatry 43:100–102
Newton RE, Marunycz JD, Alderdice MT, Napoliello MJ (1986) Review of the side-effect profile of buspirone. Am J Med 80:17–21
Nicholson AN, Stone BM (1979) Effect of some stimulants on sleep in man. Br J Pharmacol 66:476P
Nicholson AN, Stone BM (1983) The H1-antagonist mequitazine: studies on performance and visual function. Eur J Clin Pharmacol 25:563–566
Nicholson AN, Stone BM (1986) Antihistamines: impaired performance and the tendency to sleep. Eur J Clin Pharmacol 30:27–32
Nicholson AN, Pascoe PA, Turner C, Ganellin CR, Greengrass PM, Casy AF, Mercer AD (1991) Sedation and histamine H1-receptor antagonism: studies in man with the enantiomers of chlorpheniramine and dimethindene. Br J Pharmacol 104:270–276
Oswald I (1969) Unusual effect of fenfluramine. Br Med J 4:806
Oswald I, Adam K, Borrow S, Idzikowski G (1979) The effects of two hypnotics on sleep, subjective feelings and skilled performance. In: Passouant J, Oswald I (eds) Pharmacology of the states of awareness. Pergamon, New York, pp 51–63
Passouant P, Cadilhac J, Ribstein M (1972) Les privations de sommeil avec mouvements oculaires par les anti-depresseurs. Rev Neurol 127:173–192
Peter JH, Gassel W, Mayer J, Heurer-Mayer B, Penzel T, Schneider H (1989) Effects of Cilazapril in hypertension, sleep, and apnea. Am J Med 87:72S–78S
Physician’s Desk Reference (1993) Medical Economics, New Jersey, p 2687
Pohl R, Gershon S (1981) Nomifensine: a new antidepressant. Psychiatr Ann 11:391–395
Poitras R (1980) A propos d’episodes d’amnesies anterogrades associes a l’utilisation du triazolam. Union Med Can 109:427–429
Pradalier A, Giroud M, Dry J (1987) Somnambulism, migraine and propranolol. Headache 27:143–145
Prien RF, Klett CJ, Caffety EM Jr (1973) Lithium carbonate and imipramine in prevention of affective episodes. Arch Gen Psychiatry 29:420–425
Quitkin F, Rifkin A, Kane J (1978) Prophylactic effect of lithium and imipramine in unipolar and bipolar II patients: a preliminary report. Am J Psychiatry 135:570–572
Rajala R, Partinen M, Sane T, Pelkonen R, Huikuri K, Seppalainen A-M (1991) Obstructive sleep apnoea in morbidly obese patients. J Intern Med 230:125–129
Rall TW (1990a) Hypnotics and sedatives; ethanol. In: Goodman, Gilman’s (eds) The pharmacological basis of therapeutics, 8th edn. Pergamon Press, New York, pp 345–382
Rall TW (1990b) Drugs used in the treatment of asthma. In: Goodman, Gilman’s (eds) The pharmacologic basis of therapeutics, 8th edn. Pergamon Press, New York, pp 618–637
Regestein QR, Reich P (1985) Agitation observed during treatment with newer hypnotic drugs. J Clin Pharmacol 46:280–283
Rhind GB, Connaughton JJ, McFie J, Douglas NJ, Flenley DC (1985) Sustained release choline theophyllinate in nocturnal asthma. Br Med J 291:1605–1607
Rifkin A, Siris S (1987) Drug treatment of acute schizophrenia. In: Meitzer HY (ed) Psychopharmacology. The third generation of progress. Raven, New York, pp 1095–1101
Robinson RW, Zwillich CW, Bixler EO, Cadieux RJ, Kales A, White DP (1987) Effects of oral narcotics in sleep disordered breathing in healthy adults. Chest 91:197–203
Robinson RW, Zwillich CW (1994) Drugs and sleep respiration. In: Kryger MH, Roth T, Dement WC (eds) Principles and practice of sleep medicine, 2nd edn. Saunders, Philadephia, pp 603–620
Roth T, Zorick F (1987) Sedative effects of antihistamines. J Allergy Clin Immunol 80:94–98
Roth T, Kramer M, Lutz T (1976) Intermediate use of triazolam: a sleep laboratory study. J Int Med Res 4:59–62
Roth T, Roehrs T, Koshorek J, Sicklesteel BA, Zorick F (1987) Sedative effects of antihistamines. J Allergy Clin Immunol 80:94–98
Rothschild AJ (1985) Mania after withdrawal of isocarboxazid. J Clin Psychopharmacol 5:340–342
Rubinstein S, Silver LB, Licamele WL (1994) Clonidine for stimulant-related sleep problems. J Am Acad Child Adoless Psychiatry 33:281–282
Rudolf M, Geddes DM, Turner JA, Saunders KF (1978) Depression of central respiratory drive by nitrazepam. Thorax 33:97–100
Rundell OH, Lester BK, Griffiths WJ, Williams HL (1972) Alcohol and sleep in young adults. Psychopharmacologia 26:201–218
Safar P, Escarraga LA, Chang F (1959) Upper airway obstruction in the unconscious patients. J Appl Physiol 14:760–764
Saletu B, Grunberger J, Anderer P, Barbanoj MJ (1988) Pharmacodynamic studies of a combination of lorazepam and diphenhydramine and its single components: electroencephalographic brain mapping and safety evaluation. Curr Ther Res Clin Exp 44:909–937
Samuels SI, Rabinov W (1986) Difficulty reversing drug-induced coma in a patient with sleep apnea. Anesth Analg 65:1222–1224
Sandblom RE, Matsumoto AM, Schoene RB, Lee KA, Giblin EC, Bremner WJ (1983) Obstructive sleep apnea syndrome induced by testosterone administration. N Engl J Med 308:508–510
Santiago TV, Goldblatt K, Winters K, Pugliese AC, Edelman NH (1980) Respiratory consequences of methadone: the response to added resistance to breathing. Am Rev Respire Dis 122:623–628
Schenck CH, Bundlie SR, Smith SA, Ehinger MG, Mahowald MW (1986) REM behavior disorder in a 10 year old girl and aperiodic REM and NREM sleep movements in an 8 year old brother. Sleep Res 15:162
Schenck CH, Hurwitz TD, Mahowald MW (1988) REM sleep behavior disorder. Am J Psychiatry 145:652
Schenck CH, Mahowald MW, Kim SW, O’Conner KA, Hurwitz TD (1992) Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 15:226–235
Schlauch R (1979) Hypnopompic hallucinations and treatment with imipramine. Am J Psychiatry 136:219–220
Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santon RJ, Varano LA, White DP (1986) The influence of testosterone on breathing during sleep. J Appl Physiol 61:618–623
Schoonover SC (1983) Depression. In: Bassuk EL, Schoonover SC, Gelenberg AJ (eds) The practitioner’s guide to psychoactive drugs, 2nd edn. Plenum, New York, pp 19–77
Schwab RS, Poskanzer DC, England AC, Young RR (1972) Amantadine in Parkinson’s disease. JAMA 7:792–795
Scrima L, Broudy M, Nay K, Cohn MA (1982) Increased severity of obstructive sleep apnea after bedtime alcohol ingestion: diagnostic potential, and proposed mechanism of actions. Sleep 5:318–328
Scully BE, Clynes N, Neu HC (1991) Oral ofloxacin therapy of infections due to multiply-resistant bacteria. Diagn Microbiol Infect Dis 14:435–441
Shimizu T, Ookawa M, Iijuma S, Nakamura M (1985) Effect of clomipramine on nocturnal sleep of normal human subjects. Annu Rev Pharmacopsychiat Res Round 16:138
Shore, JH, Fraunfelder FT, Meyer SM (1987) Psychiatric side effect from topical ocular timolol, a beta-adrenergic blocker. J Clin Psychopharmacol 7:264–267
Skatrud JB, Begle RL, Busch M (1988) Ventilatory effects of single, high-dose triazolam in awake human subjects. Clin Pharmacol Ther 44:684–689
Smith DE, Wesson DR, Buxton ME, Seymour RB, Ungerleider JT, Morgan JP, Mandell AJ, Jara G (1979) Amphetamine use, misuse, and abuse. In: Proceedings of the national amphetamine conference, 1978. Hall, Boston, pp 21–27
Soldatos CR, Kales A, Bixler EO, Vela-Bueno A (1985) Behavioral side effects of benzodiazepine hypnotics. Clin Neuropharmacol 8 [Suppl 1]:S112–S117
Solomon F, White C, Parron D, Mendelson WB (1979) Sleeping pills, insomnia, and medical practice. N Engl J Med 300:803–808
Starmer G (1985) Antihistamines and highway safety. Accid Anal Prev 17:311–317
Sugano T, Suenaga K, Endo S, Shimada M (1980) Withdrawal delirium in a patient with nitrazepam addiction. Jpn J EEG EMG 8:34–35
Tachibana M, Tanaka K, Hishikawa Y, Kaneko I (1975) A sleep study of acute psychotic states due to alcohol and meprobamate addiction. Adv Sleep Res 2:177–205
Tanaka K, Kameda H, Sugita Y, Hishikawa Y (1979) A case with pentazocine dependence developing delirium upon withdrawal. Psychiatr Neurol Jpn 81: 289–299
Teelucksingh S, Steer CR, Thompson CJ, Seckl JR, Douglas NJ, Edwards CRW (1991) Hypothalamic syndrome and central sleep apnoea associated with toluene exposure. Q J Med, New Series 78,286:185–190
Thorpy M J (1990) International classification of sleep disorders: diagnostic and coding manual. American Sleep Disorders Association, Rochester
Tormey WP, Buckley MP, Darragh AS (1979) Propranolol, sleep and the nocturnal release of stress hormones. J Irish Med Assoc 72:450
Vgontzas AN, Tan TL, Bixler EO, Martin LF, Shubert D, Kales A (1994) Sleep apnea and sleep disruption in obese patients. Arch Intern Med 154:1705–1711
Vogel G, Thurmond A, Gibbons P, Edwards K, Sloan KB, Sexton K (1975) The effect of triazolam on the sleep of insomniacs. Psychopharmacologia 41:65–69
Vogel GW, Barker K, Gibbons P, Thurmond A (1976) A comparison of the effects of flurazepam 30 mg and triazolam 0.5 mg on the sleep of insomniacs. Psychopharmacology 47:81–86
Volta GD, Magoni M, Cappa S, Di Monda V (1990) Insomnia and perceptual disturbances during flunarizine treatment. Headche 30:62–63
Walsh JK, Muehlback MJ, Schweitzer PK (1992) Simulated assembly line performance following ingestion of cetirizine or hydroxyzine. Ann Allergy 69:195–200
Wang M, Tu P, Chen T, Hu SY (1989) Anesthetic implications and complications of uvulopalatopharyngoplasty and sleep apnea syndrome. Anaesth Sinica 27:191–196
Ware JC, Brown FW, Moorad PJ, Pittard JT, Murphy M, Franklin D (1984) Nocturnal myoclonus and tricyclic antidepressants. Sleep Res 13:72
Wehr TA, Goodwin FK (1979) Rapid cycling in manic-depressives induced by tricyclic antidepressants. Arch Gen Psychiatry 36:555–559
Weil JV, McCullough RE, Kline JS, Sodal IE (1975) Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal men. N Engl J Med 292:1103–1106
Weiner M (1982) Sedation and antihistamines. Arzneimittelforschung 32:1193–1195
Westerlund A (1985) Central nervous system side effects with hydrophilic and lipophilic β-blockers. Eur J Clin Pharmacol 28:73–76
White DP, Cadieux RJ, Lombard RM, Bixler EO, Kales A, Zwillich CW (1985a) The effects of nasal anesthesia on breathing during sleep, am Rev Respir Dis 132:972–975
White DP, Schneider BK, Santen RJ, McDermott M, Pickett CK, Zwillich C, Weil JV (1985b) Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol 59:1452–1457
Williams AJ, Houston D, Finbert S, Lam C, Kinney JL, Santiago S (1985) Sleep apnea syndrome and essential hypertension. Am J Cardiol 55:1019–1022
Williams NR (1988) Erythromycin: a case of nightmares. BMJ 296:214
Wirz-Justice A (1983) Antidepressant drugs: effects on the circadian system. In: Wehr TA, Goodwin FK (eds). Circadian rhythms in psychiatry. Boxwood, Pacific Grove, California, pp 235–264
Woods PB, Robinson ML (1981) An investigation of the comparative liposolubilities of β-adrenoceptor blocking agents. J Pharm Pharmacol 33:172–173
Woodward JK, Munro NL (1982) Terfenadine, the first non-sedating antihistamine. Arzneimittelforschung 32:1154–1156
Wyatt RJ, Gillin JC (1976) Biochemistry and human sleep. In: Williams RL, Karacan I (eds) Pharmacology of sleep. Wiley, New York, pp 239–274
Yew WW, Wong CF, Wong PC, Lee J, Chau CH (1993) Adverse neurological reactions in patients with multidrug-resistant plumonary tuberculosis after coadministration of cycloserine and ofloxacin. Clin Infect Dis 17:288–289
Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr S (1993) The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230–1236
Yules RB, Lippman ME, Freedman DX (1967) Alcohol administration prior to sleep. Arch Gen Psychiatry 16:94–97
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kales, A., Vgontzas, A.N. (1995). Sleep Disturbances as Side Effects of Therapeutic Drugs. In: Kales, A. (eds) The Pharmacology of Sleep. Handbook of Experimental Pharmacology, vol 116. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-57836-6_20
Download citation
DOI: https://doi.org/10.1007/978-3-642-57836-6_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63372-0
Online ISBN: 978-3-642-57836-6
eBook Packages: Springer Book Archive